Indian pharmaceutical producer Claris Lifesciences Ltd. has started a sale of its U.S. injectable-drug business, which could fetch at least $500 million, people with knowledge of the matter said. Claris Lifesciences has reached out to potential ... Bloomberg, 1 month ago
Carlyle, Bain, others eyeing Claris' injectables business - VC Circle, 1 month ago
/PRNewswire/ -- Revenue Forecasting of Originator, Generic and OTC Medicines and Therapy Areas Including CNS, Cardiovascular and Cancer; Exploration of Regional Differences in Healthcare; Discussion of Domestic Manufacturers Including EMS, ...WorldNetDaily, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!